Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Aug 1;276(2):239-245.
doi: 10.1097/SLA.0000000000005476. Epub 2022 Jul 6.

Safety of Intraoperative Blood Salvage During Liver Transplantation in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Affiliations
Meta-Analysis

Safety of Intraoperative Blood Salvage During Liver Transplantation in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Virginia J Aijtink et al. Ann Surg. .

Abstract

Objective: The effects of intraoperative blood salvage (IBS) on time to tumor recurrence, disease-free survival and overall survival in hepatocellular carcinoma (HCC) patients undergoing liver transplantation were assessed to evaluate the safety of IBS.

Background: IBS is highly effective to reduce the use of allogeneic blood transfusion. However, the safety of IBS during liver transplantation for patients with HCC is questioned due to fear of disseminating malignant cells.

Methods: Comprehensive searches through June 2021 were performed in 8 databases. The methodological quality of included studies was assessed using the Robins-I tool. Meta-analysis with the generic inverse variance method was performed to calculate pooled hazard ratios (HRs) for disease-free survival, HCC recurrence and overall survival.

Results: Nine studies were included (n=1997, IBS n=1200, no-IBS n=797). Use of IBS during liver transplantation was not associated with impaired disease-free survival [HR=0.90, 95% confidence interval (CI)=0.66-1.24, P=0.53, IBS n=394, no-IBS n=329], not associated with increased HCC recurrence (HR=0.83, 95% CI=0.57-1.23, P=0.36, IBS n=537, no-IBS n=382) and not associated with impaired overall survival (HR=1.04, 95% CI=0.79-1.37, P=0.76, IBS n=495, no-IBS n=356).

Conclusions: Based on available observational data, use of IBS during liver transplantation in patients with HCC does not result in impaired disease-free survival, increased HCC recurrence or impaired overall survival. Therefore, use of IBS during liver transplantation for HCC patients is a safe procedure.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
PRISMA flow diagram.
FIGURE 2
FIGURE 2
Forest plots representing disease-free survival. A, Forest plot includes uncorrected estimates only. B, Forest plot includes corrected estimates (propensity score matching or multivariable cox regression) if available.
FIGURE 3
FIGURE 3
Forest plots representing risk for HCC recurrence. A, Forest plot includes uncorrected estimates only. B, Forest plot includes corrected estimates (propensity score matching or multivariable cox regression) only. C, Forest plot includes uncorrected estimates and corrected estimates (propensity score matching or multivariable cox regression) if available.

References

    1. Tomimaru Y, Eguchi H, Marubashi S, et al. . Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol. 2011;17:3709–3715. - PMC - PubMed
    1. Foltys D, Zimmermann T, Heise M, et al. . Liver transplantation for hepatocellular carcinoma—is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res. 2011;47:182–187. - PubMed
    1. Muscari F, Suc B, Aguirre J, et al. . Orthotopic liver transplantation with vena cava preservation in cirrhotic patients: is systematic temporary portacaval anastomosis a justified procedure? Transplant Proc. 2005;37:2159–2162. - PubMed
    1. Liu L, Wang Z, Jiang S, et al. . Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS ONE. 2013;8:e64261. - PMC - PubMed
    1. Bennett-Guerrero E, Feierman DE, Barclay R, et al. . Preoperative and intraoperative predictors of postoperative morbidity, poor graft function and early rejection in 190 patients undergoing liver transplantation. Arch Surg. 2001;136:1177–1183. - PubMed